510(k) K140857
- Device
- INFLUENZA B LINEAGE GENOTYPING KIT, CDC HUMAN INFLUENZA VIRUS REAL-TIME RT-PCR DIAGNOSTIC PANEL
- Applicant
- CENTERS FOR DISEASE CONTROL AND PREVENTION
- 510(k) number
- K140857
- Product code
- OZE
- Decision
- Substantially Equivalent (SESE)
- Decision date
- 2014-04-25
- Date received
- 2014-04-03
- Regulation
- 866.3980
- Classification name
- Influenza A And Influenza B Multiplex Nucleic Acid Assay
- Medical specialty
- Microbiology
- Review panel
- Microbiology
- Device class
- 2
- Clearance type
- Special
- Statement or summary
- Summary
- Third party reviewed
- No
Applicant Contact#
- Contact
- CDR YON YU, PHARM.D.
- Address
- 1600 Clifton Rd., Ms-C18 Atlanta GA US 30333 30333
FDA Registration Numbers#
- 3007799234
- 3019946577
- 1650733
- 3004141078
- 2243471
- 3008632402
- 3010770794
- 1050190
- 9610126
- 3003795116
- 3002773840
- 3005360469
- 3012494290
- 3013019728
- 3006028115
- 3029059580
- 3003018722
- 1221359
- 3023372670
- 3038610665
- 1528450
Source Documents#
Other 510(k) Records For Product Code OZE #
| 510(k) | Device | Applicant | Decision date |
|---|---|---|---|
| K243274 | CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit (VER 2); Influenza A SubTyping Kit (VER 4); Influenza B Genotyping Kit (VER 1.1 and 2); and Influenza A/H5 Subtyping Kit (VER 4) | Centers for Disease Control and Prevention | 2025-07-11 |
| K243931 | CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit (VER 2); Influenza A Subtyping Kit (VER 4); Influenza B Lineage Genotyping Kit (VER 1.1 and 2); and Influenza A/H5 Subtyping Kit (VER 4) | Centers for Disease Control and Prevention | 2025-03-14 |
| K241110 | CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel, Influenza A Subtyping Kit (Ver4) | Centers for Disease Control and Prevention | 2024-05-21 |
| K230236 | Lyra Influenza A+B Assay | Quidel Corporation | 2023-03-03 |
| K220801 | ID Now Instrument, ID Now Influenza A & B 2, ID NOW Strep A 2 | Abbott Diagnostics Scarborough, Inc. | 2022-06-24 |
| K200370 | CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel, Influenza A/B Typing Kit, CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel, Influenza A Subtyping Kit, CDC Human Influenza Virus Real-time RT-PCR, Influenza A/H5 Subtyping Kit | Centers for Disease Control and Prevention | 2020-03-10 |
| K182513 | FluChip-8G Influenza A+B Assay | Indevr, Inc. | 2019-04-22 |
| K190302 | CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel, Influenza A/B Typing Kit, CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel, Influenza A Subtyping Kit, CDC Human Influenza Virus Real-time RT-PCR, Influenza B Lineage Genotyping Kit, CDC Human Influenza Virus Real-time RT-PCR, Influenza A/HS Subtyping Kit | Centers for Disease Control and Prevention | 2019-03-27 |
| K190204 | ID NOW Influenza A & B 2 | Alere Scarborough, Inc. | 2019-03-18 |
| K181736 | CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage Genotyping Kit, | Centers For Disease Control and Prevention (CDC) | 2018-07-30 |
| K171641 | Accula Flu A/Flu B Test | Mesa Biotech, Inc. | 2018-02-06 |
| K172091 | CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel, Influenza A/B Typing Kit, CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel, Influenza A Subtyping Kit, CDC Human Influenza Virus Real-time RT-PCR, Influenza B Lineage Genotyping Kit, CDC Human Influenza Virus Real-time RT-PCR, Influenza A/H5 Subtyping Kit | Centers for Disease Control and Prevention | 2017-08-09 |
| K161556 | CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel, Influenza A Subtyping Kit | Centers For Disease Control and Prevention (CDC) | 2016-06-30 |
| K153148 | CDC Human Influenza Virus Real- time RT-PCR Diagnostic Panel, Influenza A/H5 Subtyping | Centers For Disease Control and Prevention (CDC) | 2015-12-01 |
| K141859 | CDC HUMAN INFLUENZA VIRUS REAL-TIME RT-PCR DIAGNOSTIC PANEL, INFLUENZA A/H5 SUBTYPING | Centers for Disease Control and Prevention | 2014-08-01 |
Legacy Summary#
summary
FDA Review#
Decision Summary